Chester County News and Community Website
As the COVID-19 pandemic upends society, MyChesCo is gathering in one place all the latest news and insights impacting Chester County, Pennsylvania.
Information About COVID-19
COVID-19 is a novel strain of coronavirus that causes mild flu-like symptoms, but severe cases can be fatal.
According to the CDC, COVID-19 affects different people in different ways. Infected people have had a wide range of symptoms reported – from mild symptoms to severe illness.
Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19:
Look for emergency warning signs for COVID-19. If someone is showing any of these signs, seek emergency medical care immediately:
If you develop symptoms, the Chester County Health Department is advising you to stay home and call your healthcare provider.
If symptoms worsen, contact your healthcare provider or call 9-1-1 emergency and seek care immediately. Let them know of your potential exposure to COVID-19.
For general questions about COVID-19, call the Pennsylvania hotline at 1-877-PA-HEALTH (1-877-724-3258).
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) said it has taken a key step toward federal preparedness planning by filing an investigational new drug application for its influenza candidate …
Traws Targets Stockpile Nod as COVID Drug Outperforms Paxlovid in Trial Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) said interim results from a mid-stage clinical trial suggest its experimental COVID-19 treatment ratutrelvir may offer a differentiated alternative to Paxlovid, with …
New COVID Pill Shows Promise Against Paxlovid in Early Head-to-Head Trial Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that results from its Phase 1 proof-of-concept trial evaluating DNA-encoded monoclonal antibodies (DMAbs) for COVID-19 have been published in Nature Medicine. The …
INOVIO’s DNA-Encoded Antibody Trial Shows Durable In Vivo Expression Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has begun dosing participants in a Phase 2 clinical trial evaluating ratutrelvir, a ritonavir-free antiviral therapy for newly diagnosed COVID-19 patients. The …
Traws Pharma Begins Phase 2 Trial of Ritonavir-Free COVID-19 Treatment Ratutrelvir Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) announced it has received approval from the Human Research Ethics Committee (HREC) to begin Phase 2 clinical trials of ratutrelvir, a ritonavir-free …
Traws Pharma Receives Approval to Launch Phase 2 Trials for Ritonavir-Free COVID Treatment Read More
WILLOW GROVE, PA — A new clinical assessment from ECRI, a leading nonprofit health technology evaluator, concludes that mRNA COVID-19 vaccines are both safe and effective for pregnant women and …
New ECRI Report Finds COVID-19 mRNA Vaccines Safe and Effective for Pregnant Women and Their Babies Read More
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has announced the distribution of over $3.5 million in refunds to consumers harmed by “The Credit Game,” a credit-repair scheme found to have …
FTC Provides $3.5 Million in Refunds to Victims of Credit-Repair Scheme Read More
PHILADELPHIA, PA — Xing Zheng, 35, of Queens, New York, was sentenced to 28 months in federal prison and three years of supervised release, according to an announcement by United …
Mastermind or Middleman? New York Man Sentenced in $3 Million Fraud Scheme That Exploited U.S. Emergency Funds Read More NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ET, where the company will spotlight its …
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its investigational oral treatment for COVID-19. Presented at the International Conference for …
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment Read More